About synapse FAQ ID: #018
Q:

What kind of company is Kosei Pharmaceutical Co., Ltd.?

A:

Kosei Pharmaceutical Co., Ltd. is a long-established Japanese pharmaceutical wholesaler and specialized trading house headquartered in Osaka, established in 1952. With over 70 years of heritage, the company is a global leader that integrates a robust domestic foundation with the cutting-edge digital platform, 'synapse.'


Corporate Attributes & Core Competencies

Proven Reliability & Market Presence:
As an independent wholesaler, we maintain a powerful network of approximately 12,000 medical institutions and pharmacies across Japan.


Pioneer in Global Distribution:
We operate 'synapse,' a proprietary cross-border platform designed to connect the Japanese pharmaceutical market with the world, serving as a vital bridge for the stable supply of high-quality medicines to global healthcare settings.


Strong Governance & Financial Stability:
As a wholly-owned subsidiary of Clinphar Inc. (Tokyo Stock Exchange: 432A), we operate with the highest standards of transparency and regulatory compliance required of a publicly-listed group.


Specialized Supply Chain Capabilities:
We offer optimized domestic and international logistics, specializing in rapid response to urgent medical needs and the handling of medications requiring strict GDP-compliant cold chain management.


Corporate Profile

  • Official Name: Kosei Pharmaceutical Co., Ltd.

  • Established: July 1952 (Over 70 years of operation)

  • Headquarters: 5th Floor, OMM Building, 1-7-31 Otemae, Chuo-ku, Osaka, Japan

  • President & CEO: Kohei Toda

  • Parent Company: Clinphar Inc. (TSE: 432A)

Back to FAQ Portal